Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Kouranos, A. Rapti, E. Gialafos, K. Aggeli, M. Ntouskou, A. Kallianos, O. Anagnostopoulou, G. Tzelepis (Athens, Greece). Assessment of cardiac involvement in patients with sarcoidosis. Eur Respir J 2011; 38: Suppl. 55, 3758

Member's Comments

No comment yet.

Related content which might interest you: Management of cardiac sarcoidosis Source: Virtual Congress 2020 – Severe thoracic sarcoidosis : where do we stand ? Year: 2020 Timing of cardiac sarcoidosis in patients with sarcoidosis> Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Treatment and management of cardiac sarcoidosis Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Risk of underdiagnoses of cardiac sarcoidosis by routine electrocardiogram and echocardiogram in patients with biopsy-proven extracardiac sarcoidosis Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype Year: 2018 Cardiac involvement in sarcoidosis evaluated by echocardiography Source: Eur Respir J 2002; 20: Suppl. 38, 458s Year: 2002 Cardiac involvement in sarcoidosis evaluated by echocardiography Source: Eur Respir J 2001; 18: Suppl. 33, 225s Year: 2001 Comprehensive evaluation of airway involvement in pulmonary sarcoidosis Source: ERJ Open Res, 3 (1) 00105-2016; 10.1183/23120541.00105-2016 Year: 2017 Evaluation of the functional parameters in scleroderma cases with pulmonary involvement Source: Annual Congress 2009 - Respiratory physiology Year: 2009 Phenotypes of organ involvement in sarcoidosis Source: Eur Respir J, 51 (1) 1700991; 10.1183/13993003.00991-2017 Year: 2018 Cognitive disfunction in patients after COVID-19 with lung involvement Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021 Decreased aortic stiffness in with early grade pulmonary sarcoidosis patients Source: International Congress 2016 – Sarcoidosis Year: 2016 Vascular dysfunction in patients with pulmonary sarcoidosis Source: Annual Congress 2007 - Sarcoidosis: various aspects Year: 2007 Lung function at patients with sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002 Assessment of disease severity using imaging scores in pulmonary sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Importance of fatigue measurement in sarcoidosis patients Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011 Renal involvement in chronic pulmonary sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 550s Year: 2005 Cardiac sarcoidosis Source: Eur Respir Monogr 2022; 96: 142-159 Year: 2022 Clinical and morphological signs of liver damadge in patients with pulmonary sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011